HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas Moulinet Selected Research
Thomas Moulinet Research Topics
Disease
4
Thrombocytopenia (Thrombopenia)
11/2023 - 11/2019
4
Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 11/2019
3
Infections
12/2023 - 04/2022
3
Neoplasms (Cancer)
11/2023 - 01/2021
2
VEXAS syndrome
12/2023 - 01/2023
2
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2023 - 01/2018
2
Inflammation (Inflammations)
10/2023 - 01/2022
2
Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2023 - 10/2022
2
Systemic Scleroderma (Systemic Sclerosis)
10/2022 - 01/2021
2
Uveitis
01/2022 - 01/2022
2
Macular Edema
01/2022 - 01/2022
2
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2022 - 06/2016
2
Thrombosis (Thrombus)
01/2021 - 11/2019
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
02/2024
1
Atopic Dermatitis (Atopic Eczema)
10/2023
1
Diarrhea
10/2023
1
Hypersensitivity (Allergy)
10/2023
1
Ichthyosis (Xeroderma)
10/2023
1
Arthralgia (Joint Pain)
10/2023
1
Scleritis (Episcleritis)
05/2023
1
Erdheim-Chester Disease
01/2023
1
Histiocytosis
01/2023
1
Asthma (Bronchial Asthma)
01/2023
1
Fibrosis (Cirrhosis)
10/2022
1
Vasculitis (Vasculitides)
04/2022
1
Cryoglobulinemia
04/2022
1
Low Vision (Subnormal Vision)
01/2022
1
Hemolytic Anemia
01/2022
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2022
1
Retinal Vasculitis
01/2022
1
Antisynthetase syndrome
01/2021
1
Connective Tissue Diseases (Connective Tissue Disease)
01/2021
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Autoimmune Diseases (Autoimmune Disease)
01/2018
1
Ischemia
06/2016
Drug/Important Bio-Agent (IBA)
5
Antiphospholipid Antibodies
IBA
11/2022 - 11/2019
3
Glucocorticoids
IBA
12/2023 - 04/2022
3
Antibodies
IBA
01/2022 - 11/2019
2
Janus Kinase Inhibitors
IBA
12/2023 - 10/2022
2
Enzymes
IBA
12/2023 - 01/2023
2
Inosine Triphosphate (ITP)
IBA
11/2023 - 01/2018
2
Rituximab (Mabthera)
FDA Link
05/2023 - 04/2022
2
Lupus Coagulation Inhibitor (Lupus Anticoagulant)
IBA
01/2022 - 11/2019
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2022 - 01/2022
2
Immunoglobulin M (IgM)
IBA
01/2022 - 11/2019
1
Azacitidine (5 Azacytidine)
FDA Link
12/2023
1
Vaccines
IBA
11/2023
1
Complement System Proteins (Complement)
IBA
11/2023
1
Histamine (Histamine Dihydrochloride)
FDA Link
10/2023
1
baricitinib
IBA
10/2023
1
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
05/2023
1
Prednisone (Sone)
FDA Link
Generic
01/2023
1
mepolizumab
IBA
01/2023
1
dupilumab
IBA
01/2023
1
Alkylating Agents
IBA
04/2022
1
belimumab
IBA
04/2022
1
Adalimumab (Humira)
FDA Link
01/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022
1
tocilizumab (atlizumab)
FDA Link
01/2022
1
Infliximab (Remicade)
FDA Link
01/2022
1
Anticardiolipin Antibodies
IBA
11/2019
1
Immunoglobulin G (IgG)
IBA
11/2019
Therapy/Procedure
3
Therapeutics
11/2023 - 01/2023
1
Immunotherapy
11/2023
1
Splenectomy
01/2018
1
Stents
06/2016